Company / Cash & Equivalents
Lifeward Ltd. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$2.2M
FY2025
5-year range
$2.2M / $88.3M
FY2021-FY2025
Trend
-67.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 4 consecutive years, from $88M in FY2021 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -36.1%.
Declined from $28M to $2M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -68.3%
- 5-Year CAGR
- -36.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- Lifeward Ltd.'s cash & equivalents has declined for 4 consecutive years.
- 5-year CAGR of -36.1%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 67.8% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2M | -67.8% |
| FY2024 | $6.7M | -76.0% |
| FY2023 | $28.1M | -58.6% |
| FY2022 | $67.9M | -23.1% |
| FY2021 | $88.3M | +334.1% |
| FY2020 | $20.4M | +25.2% |
| FY2019 | $16.3M | +70.3% |
| FY2018 | $9.5M | -34.5% |
| FY2017 | $14.6M | -65.2% |
| FY2016 | $41.8M | +372.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026